These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15739602)

  • 1. Recombinant activated factor VII therapy in acquired hemophilia of the elderly.
    Dragani A; Di Bartolomeo E; La Barba G; Cavoni A; Lanzillotta P; Guizzardi G; Davì G
    Aging Clin Exp Res; 2004 Dec; 16(6):487-9. PubMed ID: 15739602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
    Scharrer I
    Haemophilia; 1999 Jul; 5(4):253-9. PubMed ID: 10469179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study.
    Zhang XH; Zhu XL; Niu T; Sun J; Liu H; Feng R; Yang LH; Wei Q; Ma QH; Wang QM; Feng FE; Fu HX; Mo XD; Lv M; Huang XJ
    Thromb Res; 2015 May; 135(5):835-40. PubMed ID: 25747536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
    Kubisz P; Plamenová I; Stasko J; Dobrotová M; Hollý P
    Thromb Haemost; 2010 Apr; 103(4):868-70. PubMed ID: 20135075
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe acquired hemophilia A successfully treated with activated recombinant human factor VII.
    Papadaki HA; Xylouri I; Valatas W; Petinarakis J; Kontopoulou I; Eliopoulos GD
    Ann Hematol; 1998 Sep; 77(3):123-5. PubMed ID: 9797081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant activated factor VII in patients with acquired haemophilia.
    Tiede A; Amano K; Ma A; Arkhammar P; El Fegoun SB; Rosholm A; Seremetis S; Baudo F
    Blood Rev; 2015 Jun; 29 Suppl 1():S19-25. PubMed ID: 26073365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data.
    Amano K; Seita I; Higasa S; Sawada A; Kuwahara M; Shima M
    Haemophilia; 2017 Jan; 23(1):50-58. PubMed ID: 27457022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
    Baudo F; de Cataldo F; Gaidano G;
    Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.
    Liebman HA; Chediak J; Fink KI; Galvez AG; Shah PC; Sham RL
    Am J Hematol; 2000 Mar; 63(3):109-13. PubMed ID: 10679799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII.
    Leebeek FW; Kappers-Klunne MC; Jie KS
    Haemophilia; 2004 May; 10(3):250-3. PubMed ID: 15086322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A.
    Okayama Y; Bingo M; Sakatoku K; Okamura H; Nanno S; Nishimoto M; Nakashima Y; Koh H; Hino M; Nakamae H
    Blood Coagul Fibrinolysis; 2023 Sep; 34(6):419-422. PubMed ID: 37577920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors.
    Schmidt ML; Gamerman S; Smith HE; Scott JP; DiMichele DM
    Am J Hematol; 1994 Sep; 47(1):36-40. PubMed ID: 8042614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postsurgical coagulopathy in a hemophilia A patient with inhibitors: efficacy of recombinant factor VIIa.
    Saeki N; Mochizuki S; Fujii T; Kawamoto M
    J Anesth; 2014 Aug; 28(4):621-4. PubMed ID: 24389884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
    Biron-Andréani C; Dupeyron G; Mainemer M; Schved JF
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):215-6. PubMed ID: 11414637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitor.
    Stewart AJ; Hanley JP; Ludlam CA
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S93-5. PubMed ID: 9819036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faster onset of effect and greater efficacy of NN1731 compared with rFVIIa, aPCC and FVIII in tail bleeding in hemophilic mice.
    Holmberg HL; Lauritzen B; Tranholm M; Ezban M
    J Thromb Haemost; 2009 Sep; 7(9):1517-22. PubMed ID: 19566792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?
    Brackmann HH; Effenberger W; Hess L; Schwaab R; Oldenburg J
    Eur J Haematol Suppl; 1998; 63():18-23. PubMed ID: 9882928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.